Navigenics, the Redwood Shores, CA company that I read about in Technology Review’s Jan/Feb 2008 issue brought me back to the beautiful dilemmas of placebo drugs, Matrix and Minority Report.
Navigenics is the leading developer of a genetics test that has the potential to tell its customers the probability of getting a heart attack or Alzheimer’s [...]

• Comments

Ok, I don’t have the invite yet, but I am impatiently waiting for it! After Gmail’s easing effect on my personal e-mail management cycle, I expect the same thing for my corporate e-mail in Procter & Gamble. After the trial, I even plan to propose that to our IT dept.  Just as I talked, what [...]

• Comments

I love TechCrunch. I start the day with them, and I end the day with them too. But I took them at their face value: reporting news from tech world. The following post on possible moves of Yahoo and the pro/con analysis surely exceeds their work responsibility. If TechCrunch guys continue to do so, McKinsey [...]

• Comments

I had a year-old post on multiple identity crisis and the collective wasted time of humans in filling registration data for each and every web 2.0 avenue. Add them the ineligible password phrases and global science and technology loses thousands of hours of brain activity. OpenID is the solution to preserve those hours, brain activity [...]

• Comments

Because they still make smart moves that can only be expected from a start-up, even though they are huge. And they are agile risk-takers too.
Take a look at what products/services they are rolling out and you will get what I see. Just recently, they put the latest feature into amazonmp3, with DRM-free music and [...]

• Comments